Understanding Heart Muscle Growth (Cardiac Hypertrophy)

Cardiac hypertrophy is an increase in cardiomyocyte size (and sometimes number) leading to thickened ventricular walls. It can be physiological (adaptive) or pathological (maladaptive).

Physiological Hypertrophy

  • Trigger: Chronic endurance/strength exercise (athlete's heart).
  • Features: Proportional wall thickening, normal/chamber dilation, preserved/enhanced systolic & diastolic function, reversible with detraining.
  • Molecular drivers: IGF-1/PI3K/Akt pathway; physiological gene program.

Pathological Hypertrophy

  • Triggers: Pressure overload (hypertension, aortic stenosis), volume overload (valvular regurgitation), neurohormonal activation (RAAS, catecholamines), genetic mutations (sarcomere proteins).
  • Features: Disproportionate thickening, fibrosis, fetal gene reactivation (ANP, BNP, β-MHC), impaired relaxation (diastolic dysfunction), progression to heart failure.
  • Molecular drivers: Calcineurin/NFAT, MAPK, Gq signaling; maladaptive gene program.

Clinical Distinction

FeaturePhysiologicalPathological
Wall thickness≤13 mm (often 10-13)>13 mm, often asymmetric
Chamber sizeNormal or mildly enlargedNormal or reduced
Diastolic functionNormal/supernormalImpaired
FibrosisAbsentPresent
ECGVoltage criteria may be met, but normal ST-TST-T changes, strain pattern
ReversibilityYes (detraining)Partial with treatment

Management

Treat underlying cause (BP control, valve repair/replacement). Regression of pathological hypertrophy improves outcomes. Genetic counseling for inherited forms (HCM).

Muscle Strains - Related Articles